Vaccines
Areas of Partnering Interest
- Novel technologies for antigen selection, discovery, and identification
- Vaccines for Infectious Disease, Cancer, and Respiratory Disease
- Novel adjuvants and immunomodulators
- Ideally, pre-clinical efficacy or clinical proof of concept achieved
- Novel viral vector approaches
- Novel delivery mechanisms
- Novel approaches to production of virus-like particles

Jeff Southerton
Submit your idea
"Pfizer is committed to flexible, transparent and mutually beneficial long-term relationships with its partners. By joining forces, we can bring quality therapies to patients worldwide. Let's work together for a healthier world."